Rossari BiotechNSE:ROSSARI -2.22%84 Gross Margin % is 27.62% as of Mar. 2026, which is 10% below its 10-year median of 30.85. GuruFocus rates NSE:ROSSARI with a GF Score™ of 84/100 and a GF Value™ of ₹998.00 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 1,561 Chemicals companies, Rossari Biotech ranks better than 66.18% on this metric.
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Rossari Biotech had a gross margin of 27.62% for the quarter that ended in Mar. 2026 => Competition eroding margins
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Rossari Biotech Gross Margin % Related Terms
Rossari Biotech Gross Margin % Historical Data
* Premium members only.
The historical data trend for Rossari Biotech's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:ROSSARI vs LIN, SHW, ECL: Gross Margin % Comparison
For the Specialty Chemicals subindustry, Rossari Biotech's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Rossari Biotech Gross Margin % vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Rossari Biotech's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Rossari Biotech's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Rossari Biotech (NSE:ROSSARI) has a Gross Margin % of 27.62% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Rossari Biotech and its competitors. This is 10% below median its historical median of 30.85. Over the past decade, Rossari Biotech's Gross Margin % has ranged from 24.52 to 36.29. According to the industry distribution chart, Rossari Biotech ranks #528 out of 1561 companies in the Chemicals industry, placing it in the top 33.8%.
Is Rossari Biotech's Gross Margin % too high?
Rossari Biotech's current Gross Margin % of 27.62% is 10% below median its 10-year median of 30.85. Over the past 10 years, this metric has ranged from a low of 24.52 to a high of 36.29. The Chemicals industry median Gross Margin % is 23.35. Rossari Biotech's value of 27.62% is 18.3% above this industry median. Based on the distribution chart, Rossari Biotech ranks #528 out of 1561 companies in the Chemicals industry, which is above the industry midpoint. Overall, Rossari Biotech has a GF Score™ of 84/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Rossari Biotech's Gross Margin % compare to LIN and SHW?
According to the Chemicals industry distribution chart, Rossari Biotech ranks #528 out of 1561 companies for Gross Margin %. This puts Rossari Biotech in the upper half of its industry. The industry median Gross Margin % is 23.35. Rossari Biotech's value of 27.62% is 18.3% above this benchmark. Historically, Rossari Biotech's own Gross Margin % has ranged from 24.52 to 36.29 over the past decade. While the company's 10-year median is 30.85 vs. the industry median of 23.35, Rossari Biotech has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Chemicals company?
The median Gross Margin % among Chemicals companies is 23.35, based on 1,561 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Rossari Biotech's current Gross Margin % of 27.62% is 18.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Rossari Biotech and its competitors. For the Chemicals industry, the median Gross Margin % is 23.35 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Rossari Biotech's current Gross Margin % is 27.62%, which is 10% below median its own 10-year median of 30.85. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rossari Biotech stock overvalued right now?
Based on GuruFocus' analysis, Rossari Biotech (NSE:ROSSARI) is currently considered Possible Value Trap. The stock's GF Value™ is ₹998.00, compared to a current price of ₹523.00 — trading 47.6% below its estimated fair value. The current Gross Margin % is 27.62%, which is 10% below median its 10-year median of 30.85 and 18.3% above the Chemicals industry median of 23.35. Rossari Biotech's overall GF Score™ is 84/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Rossari Biotech (NSE:ROSSARI), the current Gross Margin % is 27.62% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Rossari Biotech (NSE:ROSSARI) Overvalued in 2026?
Based on GuruFocus' analysis, Rossari Biotech stock appears to be undervalued.
The current stock price of ₹523.00 is trading 47.6% below its estimated GF Value™ of ₹998.00.
GuruFocus considers Rossari Biotech to be Possible Value Trap.
Key valuation signals for NSE:ROSSARI:
Gross Margin %: 27.62% (10% below median its 10-year median of 30.85)
GF Value™: ₹998.00 vs. price of ₹523.00 (47.6% below fair value)
Industry Position: 18.3% above the Chemicals median (#528 of 1561)
No single metric tells the full story. See the NSE:ROSSARI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Rossari Biotech Ltd is a specialty chemical manufacturing company. It provides customized solutions to specific industrial and production requirements of its customers in the FMCG, apparel, poultry, and animal feed industries through its product portfolio comprising home, personal care, and performance chemicals; textile specialty chemicals; and animal health and nutrition products. Its business is organized into three categories: home, personal care, and performance chemicals; textile specialty chemicals; and animal health and nutrition products. Its products include soaps and detergents, paints, inks and coatings, ceramics and tiles, water treatment chemicals, pulp and paper, and cleaning chemical formulations, among others. The company generates the majority revenue from India.
84GF Score
Get the complete analysis for NSE:ROSSARI
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:ROSSARI has been successfully added to your 
